| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3977920 | Brachytherapy | 2010 | 9 Pages |
Abstract
Our data indicate that treatment with GliaSite balloon brachytherapy is feasible and safe, while rendering acceptable local control and minimal acute and long-term toxicities for newly diagnosed and recurrent CNS malignancies. These encouraging results compel us to embark on testing larger numbers of patients with this treatment modality.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
A. Gabriella Wernicke, David L. Sherr, Theodore H. Schwartz, Susan C. Pannullo, Philip E. Stieg, John A. Boockvar, Jennifer A. Moliterno, Jana Ivanidze, Samuel Trichter, Albert M. Sabbas, Bhupesh Parashar, Dattatreyudu Nori,